Mass spectrometry in the integrated strategy for the structural analysis of protein variants.
A significant proportion of genetic disorders are caused by point mutations in proteins, and many variants of haemoglobin have been characterized by mass spectrometry. The strategy employs fast atom bombardment and/or tandem mass spectrometry of enzymatically digested peptides for elucidating the type and position of the mutations. Electrospray ionization mass spectrometry is useful for detecting mutations in the intact protein molecule, but the competence diminishes with increasing mass or increasing number of 13C atoms. Recent developments of DNA techniques requires us to re-evaluate the status of mass spectrometry in this field. The role of mass spectrometry in the structural analysis of protein variants is discussed, and is compared with chemical methods and DNA strategies.
Wada
Y
Y
Department of Molecular Medicine, Osaka Medical Centre for Maternal and Child Health, Japan.
D000595:Amino Acid Sequence; D014644:Genetic Variation; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods; D008969:Molecular Sequence Data; D017354:Point Mutation; D011506:Proteins / Q000235:genetics*; D016339:Spectrometry, Mass, Fast Atom Bombardment
D011506:Proteins